|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 180.40 GBX | +1.98% |
|
-2.38% | -8.89% |
| 05-13 | Activist investor pressures CVS to buy back GBP100 million in shares | AN |
| 05-08 | Agronomics' Meatly Raises GBP17.5 Million for UK Bioreactor Facility | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.72 | 5.2 | 4.96 | 4.66 | 5.44 | |||||
Return on Total Capital | 4.24 | 5.99 | 5.79 | 5.52 | 6.52 | |||||
Return On Equity % | 10.29 | 12.29 | 9.71 | 7.87 | 8.9 | |||||
Return on Common Equity | 10.29 | 12.29 | 9.71 | 7.87 | 8.9 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 48.97 | 49.11 | 47.45 | 46.82 | 46.87 | |||||
SG&A Margin | 39.8 | 38.2 | 38.24 | 38.76 | 38.04 | |||||
EBITDA Margin % | 11.47 | 12.95 | 12.13 | 10.72 | 11.75 | |||||
EBITA Margin % | 9.12 | 11.02 | 10.27 | 8.93 | 9.83 | |||||
EBIT Margin % | 9.1 | 10.97 | 10.22 | 8.91 | 9.82 | |||||
Income From Continuing Operations Margin % | 8.66 | 9.45 | 7.17 | 5.36 | 5.95 | |||||
Net Income Margin % | 8.66 | 9.45 | 7.17 | 5.36 | 5.95 | |||||
Net Avail. For Common Margin % | 8.66 | 9.45 | 7.17 | 5.36 | 5.95 | |||||
Normalized Net Income Margin | 4.68 | 6.14 | 5.75 | 4.99 | 5.47 | |||||
Levered Free Cash Flow Margin | 11.53 | 10.38 | 9.91 | 8.32 | 8.44 | |||||
Unlevered Free Cash Flow Margin | 12.55 | 11.1 | 10.67 | 9.06 | 9.17 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.65 | 0.76 | 0.78 | 0.84 | 0.89 | |||||
Fixed Assets Turnover | 2.26 | 2.87 | 2.94 | 3 | 3.21 | |||||
Receivables Turnover (Average Receivables) | 79.36 | 100.21 | 98.89 | 59.3 | 53.41 | |||||
Inventory Turnover (Average Inventory) | 7.96 | 7.97 | 7.64 | 7.62 | 7.7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.81 | 1.03 | 0.96 | 0.63 | 0.61 | |||||
Quick Ratio | 0.44 | 0.69 | 0.58 | 0.3 | 0.26 | |||||
Operating Cash Flow to Current Liabilities | 0.66 | 0.8 | 0.71 | 0.62 | 0.63 | |||||
Days Sales Outstanding (Average Receivables) | 4.59 | 3.7 | 3.68 | 6.14 | 6.82 | |||||
Days Outstanding Inventory (Average Inventory) | 45.72 | 46.53 | 47.63 | 47.77 | 47.25 | |||||
Average Days Payable Outstanding | 72.97 | 69.74 | 68.72 | 70.29 | 65.26 | |||||
Cash Conversion Cycle (Average Days) | -22.66 | -19.51 | -17.41 | -16.39 | -11.2 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 51.33 | 45.72 | 52.9 | 43.13 | 38.23 | |||||
Total Debt / Total Capital | 33.92 | 31.37 | 34.6 | 30.13 | 27.66 | |||||
LT Debt/Equity | 43.43 | 38.26 | 44.66 | 34.83 | 29.85 | |||||
Long-Term Debt / Total Capital | 28.7 | 26.26 | 29.21 | 24.34 | 21.6 | |||||
Total Liabilities / Total Assets | 42.36 | 40.61 | 44.57 | 41.29 | 40.05 | |||||
EBIT / Interest Expense | 5.56 | 9.44 | 8.44 | 7.48 | 7.78 | |||||
EBITDA / Interest Expense | 10.77 | 15.71 | 13.99 | 12.69 | 12.55 | |||||
(EBITDA - Capex) / Interest Expense | 8.9 | 12.08 | 9.54 | 9.97 | 9.93 | |||||
Total Debt / EBITDA | 2.53 | 2 | 2.28 | 1.91 | 1.62 | |||||
Net Debt / EBITDA | 2.03 | 1.31 | 1.52 | 1.65 | 1.45 | |||||
Total Debt / (EBITDA - Capex) | 3.06 | 2.6 | 3.35 | 2.43 | 2.04 | |||||
Net Debt / (EBITDA - Capex) | 2.45 | 1.7 | 2.24 | 2.1 | 1.83 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.93 | 15.31 | 6.56 | 5.16 | 0.13 | |||||
Gross Profit, 1 Yr. Growth % | 7.86 | 15.65 | 2.95 | 2.48 | 0.49 | |||||
EBITDA, 1 Yr. Growth % | -5.75 | 41.23 | -0.18 | -6.83 | 1.81 | |||||
EBITA, 1 Yr. Growth % | -5.96 | 54.3 | -0.69 | -8.6 | 0.76 | |||||
EBIT, 1 Yr. Growth % | -5.97 | 53.89 | -0.69 | -8.29 | 0.76 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 46.88 | 37.72 | -19.12 | -21.35 | 11.36 | |||||
Net Income, 1 Yr. Growth % | 46.88 | 37.72 | -19.12 | -21.35 | 11.36 | |||||
Normalized Net Income, 1 Yr. Growth % | -7.76 | 71.39 | -0.15 | -8.67 | -0.84 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 46.97 | 38.42 | -17.55 | -18.81 | 14.63 | |||||
Accounts Receivable, 1 Yr. Growth % | -34.48 | 30.7 | -9.4 | -0.8 | 23.79 | |||||
Inventory, 1 Yr. Growth % | 33.28 | 0.96 | 28.52 | -10.22 | 9.64 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -13.65 | -4.12 | 12.81 | -5.75 | -6.51 | |||||
Total Assets, 1 Yr. Growth % | -2.54 | 3.65 | 4.63 | -8.95 | -1.6 | |||||
Tangible Book Value, 1 Yr. Growth % | -91.38 | -2.19K | -43.13 | -75.28 | -7.95 | |||||
Common Equity, 1 Yr. Growth % | 6.73 | 7.5 | -2.34 | -3.57 | 0.48 | |||||
Cash From Operations, 1 Yr. Growth % | -9.34 | 36.77 | 1.25 | -16.4 | 3.81 | |||||
Capital Expenditures, 1 Yr. Growth % | -11.87 | 161.79 | 36.4 | -36.59 | 2.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -2.28 | 5.08 | 0.95 | -11.02 | -5.01 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.93 | 3.12 | 1.61 | -9.98 | -4.17 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.67 | 47.5 | 8.47 | 0 | 1.56 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.05 | 11.56 | 10.85 | 5.85 | 2.74 | |||||
Gross Profit, 2 Yr. CAGR % | 6.89 | 11.69 | 9.12 | 3.35 | 1.48 | |||||
EBITDA, 2 Yr. CAGR % | 12.17 | 10.75 | 18.73 | -3.67 | 1.26 | |||||
EBITA, 2 Yr. CAGR % | 17.32 | 14.48 | 23.79 | -4.73 | 0.52 | |||||
EBIT, 2 Yr. CAGR % | 17.29 | 14.3 | 23.62 | -4.57 | 0.69 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 80.16 | 35.91 | 5.54 | -20.24 | -6.41 | |||||
Net Income, 2 Yr. CAGR % | 80.16 | 35.91 | 5.54 | -20.24 | -6.41 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.96 | 18.08 | 30.82 | -4.51 | 0.19 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 79.81 | 36.24 | 6.83 | -18.18 | -3.53 | |||||
Accounts Receivable, 2 Yr. CAGR % | -15.06 | -7.46 | 8.82 | 29.01 | 10.82 | |||||
Inventory, 2 Yr. CAGR % | 10.78 | 16 | 13.91 | 7.42 | -0.79 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 94.57 | -9.01 | 4 | 3.11 | -6.13 | |||||
Total Assets, 2 Yr. CAGR % | 13.33 | -0.04 | 4.14 | -2.4 | -5.35 | |||||
Tangible Book Value, 2 Yr. CAGR % | -74.21 | -8.88 | 244.48 | -62.51 | -52.3 | |||||
Common Equity, 2 Yr. CAGR % | 4.9 | 6.18 | 2.46 | -2.96 | -1.57 | |||||
Cash From Operations, 2 Yr. CAGR % | 34.53 | 7.37 | 17.68 | -8 | -6.84 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.4 | 18.39 | 88.96 | -7 | -19.55 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 31.56 | 0.73 | 3.41 | -5.6 | -4.83 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 35.02 | 0.03 | 2.75 | -4.71 | -4.38 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.28 | 25.43 | 26.49 | 4.15 | 0.78 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.33 | 11.1 | 9.87 | 8.92 | 3.99 | |||||
Gross Profit, 3 Yr. CAGR % | 5.97 | 9.73 | 8.7 | 7.3 | 2.39 | |||||
EBITDA, 3 Yr. CAGR % | 5.13 | 17.86 | 6.98 | 9.43 | 0.7 | |||||
EBITA, 3 Yr. CAGR % | 7.21 | 24.25 | 9.18 | 11.89 | 0.11 | |||||
EBIT, 3 Yr. CAGR % | 7.18 | 24.1 | 9.07 | 11.91 | 0.23 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.38 | 59.82 | 14.32 | -4.31 | -10.85 | |||||
Net Income, 3 Yr. CAGR % | 16.38 | 59.82 | 14.32 | -4.31 | -10.85 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.2 | 21.53 | 11.66 | 16.05 | 0.08 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 15.59 | 59.83 | 15.24 | -2.51 | -8.45 | |||||
Accounts Receivable, 3 Yr. CAGR % | -7.94 | -1.94 | -8.11 | 29.57 | 27.25 | |||||
Inventory, 3 Yr. CAGR % | 11.41 | 7.4 | 20.03 | 5.22 | 8.15 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 53.33 | 53.68 | -2.25 | 0.64 | -0.2 | |||||
Total Assets, 3 Yr. CAGR % | 8.78 | 9.61 | 1.49 | -0.42 | -2.13 | |||||
Tangible Book Value, 3 Yr. CAGR % | -57.81 | -13.79 | -22.13 | 43.15 | -49.42 | |||||
Common Equity, 3 Yr. CAGR % | 3.11 | 5.15 | 3.26 | 0.41 | -1.83 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.89 | 32.03 | 5.29 | 5 | -4.22 | |||||
Capital Expenditures, 3 Yr. CAGR % | -5.7 | 14.06 | 24.11 | 31.31 | -4.07 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 39.63 | 21.58 | 1.07 | -1.9 | -3.2 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 40.7 | 22.98 | 0.81 | -1.93 | -2.67 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2.17 | 16.31 | 19.5 | 16.96 | 3.28 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.58 | 9.58 | 9.33 | 8.97 | 6.96 | |||||
Gross Profit, 5 Yr. CAGR % | 5.29 | 7.45 | 7.22 | 7.13 | 6.01 | |||||
EBITDA, 5 Yr. CAGR % | 1.09 | 6.3 | 8.58 | 8.72 | 4.6 | |||||
EBITA, 5 Yr. CAGR % | 0.38 | 7.75 | 11.27 | 11.73 | 5.63 | |||||
EBIT, 5 Yr. CAGR % | 0.34 | 7.66 | 11.18 | 11.72 | 5.64 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 6.35 | 10.56 | 9.9 | 21.03 | 5.53 | |||||
Net Income, 5 Yr. CAGR % | 6.35 | 10.56 | 9.9 | 21.03 | 5.53 | |||||
Normalized Net Income, 5 Yr. CAGR % | -2.53 | 6.29 | 10.01 | 10.35 | 6.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6 | 10.31 | 9.96 | 22.28 | 7.33 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.75 | -1.38 | -1.57 | 9.44 | 12.03 | |||||
Inventory, 5 Yr. CAGR % | 9.79 | 8.41 | 12.4 | 7.41 | 11.23 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 32.48 | 28.36 | 31.28 | 31.01 | -3.82 | |||||
Total Assets, 5 Yr. CAGR % | 6.61 | 6.01 | 6.67 | 4.64 | -1.3 | |||||
Tangible Book Value, 5 Yr. CAGR % | -45.08 | -10.27 | -16.28 | -38.21 | -35.99 | |||||
Common Equity, 5 Yr. CAGR % | 3.33 | 3.53 | 2.49 | 1.83 | 1.3 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.92 | 17.48 | 18.45 | 14.27 | 0.26 | |||||
Capital Expenditures, 5 Yr. CAGR % | -1.06 | 6.3 | 12.71 | 5.12 | 4.35 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.5 | 21.25 | 23.53 | 10.05 | -1.49 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 20.03 | 21.4 | 23.81 | 11.22 | -1.45 | |||||
Dividend Per Share, 5 Yr. CAGR % | 1.3 | 9.49 | 11.28 | 11.28 | 11.63 |
- Stock Market
- Equities
- PETS Stock
- Financials Pets at Home Group Plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















